Ivermectin for Early Treatment and prophylaxis of COVID-19 when exposed to patients: Author’s Perspective
Researcher Name
Prof. Abdelmonem Awad Hegazy
Name Of Journal
Biomed J Sci & Tech Res
Volume No.
40(3): 32310-32311
Date Of Publication
2021.12
Abstract
Ivermectin can be used for mass prophylaxis of the whole population at the same time especially for poor and middle-income countries that do not have the facilities to deliver good effective vaccines. Otherwise, it can be used as an emergency in case of exposure or contact with the patient and even used at the onset of infection. However, it may not be useful in treating severe cases because the virus can cause many organs to fail. We recommend further studies to confirm the effectiveness of ivermectin in preventing COVID-19.